Stocks and securities in focus
Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | -2.730% | 16.283% | -12.848% | 433.521% | 333.743% | 1327.711% | - |
Chromadex Corp | -5.950% | 15.714% | 105.063% | 129.787% | 141.791% | -57.647% | - |
Akebia Therapeutics Inc. | -16.570% | -7.610% | 20.898% | 186.855% | 47.099% | -35.672% | - |
Verastem Inc. | 0.920% | -0.901% | -7.563% | 136.315% | 45.695% | -55.781% | - |
Evolus Inc | -0.770% | 2.362% | -2.985% | 66.667% | 39.037% | 31.287% | - |
Medigene AG | -3.260% | 6.266% | 46.207% | 9.278% | 33.333% | -44.503% | -74.626% |
Gritstone Oncology Inc | -6.610% | -4.678% | -6.857% | 6.722% | 31.593% | -73.850% | - |
Atara Biotherapeutics Inc. | -7.260% | -3.703% | -14.966% | -77.418% | 18.128% | -95.196% | - |
Ardelyx Inc. | -1.160% | -6.371% | -22.654% | 73.980% | 16.955% | 25.791% | - |
Novavax Inc. | -0.130% | 1.284% | 8.900% | -22.154% | -1.075% | -97.134% | -55.020% |
Catalyst Pharmaceutical Partners Inc | 0.170% | -3.748% | 9.818% | -2.128% | -4.987% | 297.069% | 225.220% |
Carbylan Therapeutics Inc | -0.980% | -8.929% | -17.742% | 40.690% | -5.556% | -57.143% | -59.020% |
Organovo Holdings Inc. | -0.630% | 0.629% | 3.448% | -52.663% | -6.433% | -88.378% | -94.619% |
Intellia Therapeutics Inc | 0.360% | 0.196% | -15.758% | -23.170% | -11.917% | -53.501% | 80.979% |
Stratec SE | -6.120% | -6.800% | -6.028% | -37.500% | -13.399% | -66.141% | -33.860% |
Cytokinetics Inc. | -2.990% | 6.557% | -3.704% | 103.125% | -15.033% | 218.627% | - |
Syros Pharmaceuticals Inc. | -3.110% | -7.216% | -20.354% | 110.938% | -18.182% | -92.059% | - |
Salarius Pharmaceuticals Inc. | 2.420% | -18.824% | -22.617% | -76.389% | -25.405% | -98.665% | -99.992% |
Coherus Bioscien. | 2.040% | -4.545% | 1.379% | -62.652% | -27.467% | -82.542% | -82.232% |
Neptune Wellness Solutions Inc | 0.720% | - | - | - | - | - | - |
Avalo Therapeutics Inc. | 2.500% | - | - | - | - | - | - |